# Alternate Source of the Active Pharmaceutical Ingredient in Pending ANDAs:  Guidance for Industry - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/alternate-source-of-the-active-pharmaceutical-ingredient-in-pending-andas-guidance-for-industry/8a3da1bc-1ebb-48aa-a3ea-7662562c4370

> FDA guidance document: Alternate Source of the Active Pharmaceutical Ingredient in Pending ANDAs:  Guidance for Industry. Issue date: December 01, 2000. Get complete insights and analysis.

---

## Details

- Title: Alternate Source of the Active Pharmaceutical Ingredient in Pending ANDAs:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2000-12-01
- Last Changed: 2020-04-21
- Docket Number: <a href="https://www.regulations.gov/docket/None found">None found</a>

## Related Documents

- [Repeal of Section 507 of the Federal Food, Drug and Cosmetic Act _1](https://www.keypedia.com/guidances/guidance-document/repeal-of-section-507-of-the-federal-food-drug-and-cosmetic-act-_1/2e6eed29-aedc-4122-900b-0eb9b1f9aaf0)
- [Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations](https://www.keypedia.com/guidances/guidance-document/extended-release-oral-dosage-forms-development-evaluation-and-application-of-in-vitroin-vivo-correlations/c2ea6b85-0c9d-4fc1-80f0-2b5b1c5dea0e)
- [Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies](https://www.keypedia.com/guidances/guidance-document/potassium-iodide-as-a-thyroid-blocking-agent-in-radiation-emergencies/37bc2102-9236-47bf-a1a3-6fbb42443ab7)